A detailed history of California State Teachers Retirement System transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 4,496 shares of FULC stock, worth $20,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,496
Previous 4,496 -0.0%
Holding current value
$20,456
Previous $27,000 40.74%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.98 - $9.31 $26,886 - $41,857
4,496 New
4,496 $27,000
Q1 2023

May 09, 2023

BUY
$2.83 - $13.99 $11,249 - $55,610
3,975 Added 7.9%
54,299 $154,000
Q4 2022

Feb 14, 2023

BUY
$5.01 - $8.35 $21,507 - $35,846
4,293 Added 9.33%
50,324 $366,000
Q3 2022

Nov 18, 2022

BUY
$4.92 - $9.1 $45,903 - $84,903
9,330 Added 25.42%
46,031 $372,000
Q2 2022

Aug 15, 2022

BUY
$4.2 - $24.0 $8,647 - $49,416
2,059 Added 5.94%
36,701 $180,000
Q1 2022

May 16, 2022

SELL
$9.96 - $23.65 $20,537 - $48,766
-2,062 Reduced 5.62%
34,642 $819,000
Q4 2021

Feb 15, 2022

BUY
$14.0 - $28.44 $312,312 - $634,439
22,308 Added 154.96%
36,704 $649,000
Q3 2021

Nov 15, 2021

SELL
$7.28 - $30.97 $117,666 - $500,568
-16,163 Reduced 52.89%
14,396 $406,000
Q2 2021

Aug 16, 2021

BUY
$8.09 - $12.0 $39,414 - $58,464
4,872 Added 18.97%
30,559 $320,000
Q1 2021

May 18, 2021

BUY
$10.94 - $15.32 $32,666 - $45,745
2,986 Added 13.15%
25,687 $303,000
Q4 2020

Feb 16, 2021

BUY
$7.84 - $13.4 $11,995 - $20,502
1,530 Added 7.23%
22,701 $266,000
Q3 2020

Nov 17, 2020

BUY
$7.22 - $20.7 $14,165 - $40,613
1,962 Added 10.21%
21,171 $168,000
Q1 2020

May 13, 2020

BUY
$9.49 - $21.26 $116,840 - $261,753
12,312 Added 178.51%
19,209 $229,000
Q4 2019

Feb 14, 2020

SELL
$4.46 - $18.14 $789 - $3,210
-177 Reduced 2.5%
6,897 $115,000
Q3 2019

Nov 15, 2019

BUY
$6.64 - $14.89 $46,971 - $105,331
7,074 New
7,074 $47,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $237M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.